US Patent Number

5780510

Publication Date

7-14-1998

Abstract

2,4-disulfonyl α-phenyl-tert-butyl nitrone and its pharmaceutically acceptable salts are disclosed. These materials are useful as pharmaceutical agents for oral or parenteral, e.g. intravenous administration to patients suffering from acute central nervous system oxidation as occurs in a stroke or from gradual central nervous system oxidation which can exhibit itself as progressive central nervous system function loss. The materials are also used to ameliorate the side effects of oxidative-damage causing antineoplastic disease treatments.

Assignees

Oklahoma Medical Research Foundation. Oklahoma City. Okla., University of Kentucky Research Foundation, Lexington, Ky.

Application Number

663,316

Filing Date

12/22/1994

Share

COinS